Assessing Pharmacists' Understanding and Practice of Urine Drug Screening for Diabetic Neuropathy Patients treated in a pain clinic a cross sectional study in Punjab, Pak
Not Applicable
- Conditions
- Diabetic neuropathy
- Registration Number
- JPRN-UMIN000052899
- Lead Sponsor
- Shifa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
Trainees, pharmacy students and visiting pharmacists
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Evaluate the Level of Knowledge: Assess the depth of understanding among pharmacists regarding urine drug screening practices for diabetic neuropathy patients undergoing treatment at pain clinics in Punjab, Pakistan. To Assess Implementation and Compliance: Determine the extent to which pharmacists apply urine drug screening protocols in their practice for diabetic neuropathy patients within pain clinic settings in Punjab, Pakistan, and ascertain their adherence to recommended guidelines.
- Secondary Outcome Measures
Name Time Method Pharmacists' Confidence Levels: Assess the confidence levels of pharmacists in interpreting and acting upon urine drug screening results for diabetic neuropathy patients in pain clinic settings. Patient Satisfaction and Understanding: Evaluate the level of satisfaction and understanding among diabetic neuropathy patients regarding the purpose and implications of urine drug screening conducted by pharmacists within pain clinic care.